Skip to main content
SCM Lifescience Co., Ltd. logo

SCM Lifescience Co., Ltd. — Investor Relations & Filings

Ticker · 298060 ISIN · KR7298060005 KO Manufacturing
Open in API
Filings indexed 418 across all filing types
Latest filing 2022-04-04 Director's Dealing
Country KR South Korea
Listing KO 298060

About SCM Lifescience Co., Ltd.

http://www.scmlifescience.com/en/

SCM Lifescience Co., Ltd. is a biotechnology company focused on developing high-purity, high-efficacy stem cell therapeutics for difficult-to-treat and incurable diseases. The company utilizes its proprietary source technology, the Subfractionation Culturing Method, to isolate and culture potent stem cells. Its pipeline consists of allogeneic stem cell therapies targeting immunological conditions, which are undergoing clinical trials. SCM Lifescience is also establishing mass production manufacturing processes using 3D bioreactor technology and expanding its research into induced pluripotent stem cells (iPSC) and tissue engineering. The company's business areas also include contract manufacturing (CMO), contract research, consulting, and cosmetics.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form used in South Korea (often referred to as an 'Insider Trading Report') where company directors or major shareholders report their shareholdings and changes therein. This aligns perfectly with the 'Director's Dealing' (DIRS) category, which covers personal share transactions and ownership reporting by company insiders.
2022-04-04 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of a General Meeting of Shareholders (정기주주총회결과) for SCM Lifescience. It details the outcomes of various agenda items, including the approval of financial statements, election of directors and auditors, and other resolutions. This falls under the category of Declaration of Voting Results & Voting Rights Announcements, as it provides the official record of shareholder voting outcomes.
2022-03-28 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing titled 'Report on the Appointment, Dismissal, or Resignation of Outside Directors' (사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고). It details specific changes to the company's board of directors, including the appointment of a new outside director and the resignation of an existing one. This falls directly under the category of board and management changes.
2022-03-28 Korean
상호변경안내
AGM Information Classification · 100% confidence The document is a short announcement regarding a change in the company's English corporate name (SCM Lifescience Inc. to SCM Lifescience, Inc.). It is a regulatory disclosure filed with the KRX (Korea Exchange) following a general meeting. Since it does not fit into specific categories like financial reports or director dealings, and serves as a general regulatory update, it is classified as a Regulatory Filing (RNS).
2022-03-28 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from SCM Lifescience titled 'Audit Report Submission' (감사보고서 제출). It provides the auditor's opinion, key financial data, and details regarding the audit process for the fiscal year. While it contains financial data, it is a specific regulatory disclosure of the audit report's submission rather than the full 10-K annual report or a standalone audit report document. According to the 'Menu vs Meal' rule and the nature of the filing as a regulatory disclosure of audit results, it is classified as an Audit Report/Information (AR). FY 2021
2022-03-18 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for SCM Lifescience Co., Ltd. It includes the agenda for the meeting, details on electronic voting, and management information such as director activities and business reports. This type of document is standard for providing shareholders with the necessary information to vote on company matters, which falls under the Proxy Solicitation & Information Statement category.
2022-03-18 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.